Innovations in science and medicine

Woman scientist in lab examining experiment
Sectoral table C

Developments in AI and Synthetic Biology are likely to revolutionise and profoundly affect many areas of human activity, from industry to medicine.This session will consider the potential emergent “pacing problem”, that is, whether such science and technology developments will outpace the uptake capacity of regulators, and whether society will be successful in promoting the good resulting from these disruptor sciences while preventing or mitigating any unfavorable consequences.

  • (chair) Marc Saner, Full Professor (cross-appointed), Department of Geography, Environment and Geomatics, Faculty of Arts; Graduate School of Public and International Affairs, Faculty of Social Sciences; inaugural Director of the Institute for Science, Society and Policy, University of Ottawa
  • Molly S. Shoichet, Ontario’s Chief Scientist; Professor, Chemical Engineering & Applied Chemistry, University of Toronto, and Tier 1 Canada Research Chair in Tissue Engineering
  • Jennifer Kuzma, Goodnight-North Carolina GlaxoSmithKline Foundation Distinguished Professor in Social Sciences, School of Public and International Affairs (SPIA), and co-director of the Genetic Engineering and Society (GES) Center, North Carolina State University
  • Ziad Kobti, Professor and Director, School of Computer Science, University of Windsor, Chairman of the AI Association of Canada
  • (lead discussant) Michael Presley, Senior Fellow, Public and International Affairs, University of Ottawa
Back to top